Archives

by in
Entry Author Date Location
See the Agenda for ‘Reinventing Biotech’s Business Model’ Oct. 16 in SF 10/10/12 San Francisco
See What GSK, J&J, KPCB, Third Rock & Orbimed Have in Common Oct. 16 10/03/12 San Francisco
Genentech, ImmunoGen Souped-Up Breast Cancer Drug Extends Lives 10/01/12 San Francisco
Betting on Biotech to Catalyze U.S. Job Growth? Don’t Count On It 10/01/12 National
Bayer, Onyx Cancer Drug Wins FDA Approval Ahead of Schedule 09/27/12 San Francisco
Roche Deal With Tiny Sunnyvale Biotech Revives Old Family Ties 09/25/12 San Francisco
Join Us Oct. 16 for ‘Reinventing Biotech’s Business Model’ in SF 09/11/12 San Francisco
The FDA Turns Friendly Toward Pharma in 2012 09/10/12 National
Zymeworks Hits Antibody Drug Milestone For Merck, Raises $11M 09/06/12 Seattle
Genentech, ImmunoGen Breast Cancer Drug Extends Lives 08/27/12 San Francisco
Alzheimer’s R&D Isn’t Doomed, it’s Learning From Failure 08/20/12 National
Genentech Gets FDA OK of Lucentis for Diabetic Eye Disease 08/10/12 San Francisco
Join Risa Stack, Tony Coles & More for ‘Reinventing Biotech’ 08/09/12 San Francisco
U.S. Biotech Clusters Are Losing Their Anchor Tenants, and It Hurts 08/06/12 National
Aveo, Mersana, Haemonetics, & More from the Boston Life Sciences Roundup 08/03/12 Boston
Actinium Advances Armed Cancer Drugs, Preps for Wall Street Debut 08/01/12 New York
TSI Preps for Trials of New Clot-Busting Drug 07/31/12 Boston
A Lonely Voice Asking Tough Questions on Cancer Cost-Effectiveness 07/30/12 National
A Summer Reading List for Biotech Pros 07/16/12 National
Kala, ImmunoGen, Boring Biotech, & More Boston Life Sciences News 07/13/12 Boston
Life Science Innovation NW Notes: SeaGen, NanoString, Viket, & More 07/12/12 Seattle
ImmunoGen Emerges from Genentech’s Shadow With Novel Cancer Drugs 07/12/12 Boston
Crossing Sand Hill Road: SLAC, X-Ray Lasers, and the Venture Industry 07/10/12 San Francisco
The Best Boring Companies in Biotech 07/09/12 National
Novo Nordisk Weaves Itself Into Seattle Biotech, With Diabetes R&D 07/06/12 Seattle
NJ Shocker: Roche to Shutter Nutley R&D Site 06/26/12 New York
Three Good Things About BIO 2012, and Four Not-so-Good 06/18/12 National
Igenica Pulls in $33M to Fight Cancer With Antibodies 06/12/12 San Francisco
Genentech Eagerly Awaits FDA Word on 2nd Breast Cancer Drug 06/07/12 San Francisco
ASCO Wrap-Up: A Summary of This Week’s Cancer R&D Headlines 06/05/12 National
Page 2 of 13 « previous page · next page »